Curis | CRIS - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Alaunos Therapeutics USD 447K 138K 2026-03
Amgen USD 1.58B 354M 2026-03
AstraZeneca USD 5.06B 455M 2026-03
Bayer EUR 3.7B 356M 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
CSL USD 1.23B 498M 2025-12
Curis USD 1.34M 3.45M 2025-12
Eli Lilly USD 2.93B 198M 2026-03
Exelixis USD 139.6M 16.58M 2026-03
Gilead Sciences USD 1.45B 326M 2026-03
GlaxoSmithKline GBP 2.12B 558M 2026-03
Incyte USD 328.1M 62.31M 2026-03
Merck USD 2.67B 180M 2026-03
Novartis USD 3.14B 296M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.33B 419M 2026-03
Takeda JPY 292B 9.21B 2026-03
TG Therapeutics USD 73.14M 22.42M 2026-03
Verastem USD 24.44M 12.17M 2025-12
Xoma USD 11M 2.54M 2024-06